Steven H. Stein's most recent trade in Incyte Corp. was a trade of 19,932 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2026 | 19,932 | 19,932 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 101.70 per share. | 05 Jan 2026 | 15,634 | 34,203 (0%) | 0% | 101.7 | 1,589,978 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 98.77 per share. | 31 Dec 2025 | 13,292 | 49,837 (0%) | 0% | 98.8 | 1,312,851 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 102.51 per share. | 01 Dec 2025 | 20,105 | 63,129 (0%) | 0% | 102.5 | 2,060,964 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 102.04 per share. | 01 Dec 2025 | 17,093 | 83,234 (0%) | 0% | 102.0 | 1,744,170 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 102.96 per share. | 01 Dec 2025 | 2,559 | 100,327 (0%) | 0% | 103.0 | 263,475 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 102.20 per share. | 05 Nov 2025 | 5,233 | 102,886 (0%) | 0% | 102.2 | 534,813 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2025 | 2,995 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 95.76 per share. | 05 Nov 2025 | 2,995 | 107,075 (0%) | 0% | 95.8 | 286,801 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2025 | 1,194 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 83.83 per share. | 05 Nov 2025 | 1,194 | 104,080 (0%) | 0% | 83.8 | 100,093 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Nov 2025 | 1,044 | 0 | - | - | Incentive Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 95.76 per share. | 05 Nov 2025 | 1,044 | 108,119 (0%) | 0% | 95.8 | 99,973 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 67.94 per share. | 21 Jul 2025 | 3,706 | 102,886 (0%) | 0% | 67.9 | 251,786 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 30,692 | 30,692 | - | - | Performance Shares | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 27,629 | 27,629 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 68.47 per share. | 14 Jul 2025 | 14,952 | 97,466 (0%) | 0% | 68.5 | 1,023,763 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2025 | 12,277 | 106,592 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.25 per share. | 14 Jul 2025 | 1,596 | 94,315 (0%) | 0% | 68.3 | 108,927 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.98 per share. | 14 Jul 2025 | 1,555 | 95,911 (0%) | 0% | 70.0 | 108,819 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.17 per share. | 02 Jul 2025 | 12,714 | 112,418 (0%) | 0% | 68.2 | 866,713 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 37,198 | 104,165 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 20,967 | 125,132 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2025 | 28,202 | 28,202 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 72.69 per share. | 17 Jan 2025 | 12,352 | 66,967 (0%) | 0% | 72.7 | 897,867 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.46 per share. | 15 Jan 2025 | 10,692 | 79,319 (0%) | 0% | 72.5 | 774,742 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 60.63 per share. | 12 Aug 2024 | 11,608 | 90,011 (0%) | 0% | 60.6 | 703,793 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 31,088 | 31,088 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2024 | 13,895 | 103,174 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.25 per share. | 15 Jul 2024 | 1,555 | 101,619 (0%) | 0% | 64.3 | 99,909 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 59.02 per share. | 02 Jul 2024 | 8,316 | 89,279 (0%) | 0% | 59.0 | 490,810 | Common Stock |
| Repare Therapeutics Inc | Steven H. Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 54,000 | 54,000 | - | - | Stock Option (right to buy) | |
| Incyte | H. Steven Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 7,377 | 97,595 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 30,580 | 30,580 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 65.51 per share. | 03 Jan 2024 | 7,365 | 90,218 (0%) | 0% | 65.5 | 482,481 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 63.28 per share. | 01 Aug 2023 | 21,511 | 97,583 (0%) | 0% | 63.3 | 1,361,216 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 28,385 | 28,385 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 13,535 | 119,094 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 62.08 per share. | 03 Jul 2023 | 8,442 | 105,559 (0%) | 0% | 62.1 | 524,079 | Common Stock |
| Theseus Pharmaceuticals Inc | Steven H. Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 19,500 | 19,500 | - | - | Stock Option (right to buy) | |
| Theseus Pharmaceuticals Inc | Steven H. Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 3,250 | 3,250 | - | - | Restricted Stock Unit | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 27,096 | 27,096 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,980 | 114,001 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 79.78 per share. | 04 Jan 2023 | 28,399 | 109,021 (0%) | 0% | 79.8 | 2,265,672 | Common Stock |
| Theseus Pharmaceuticals Inc | Steven H. Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Oct 2022 | 60,000 | 60,000 | - | - | Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 25,665 | 25,665 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2022 | 18,941 | 141,276 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.25 per share. | 02 Jul 2022 | 3,856 | 137,420 (0%) | 0% | 79.3 | 305,588 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.63 per share. | 28 Jun 2022 | 11,488 | 122,335 (0%) | 0% | 75.6 | 868,837 | Common Stock |
| Kura Oncology Inc | Steven H. Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 23,000 | 23,000 | - | - | Option to purchase common stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2022 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 28,926 | 133,823 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 2,355 | 104,897 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Nov 2021 | 379 | 102,542 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 15,054 | 15,054 | - | - | Employee Stock Option (right to buy) | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 7,853 | 105,518 (0%) | 0% | 0 | Common Stock | |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.58 per share. | 02 Jul 2021 | 2,953 | 102,565 (0%) | 0% | 83.6 | 246,812 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.34 per share. | 02 Jul 2021 | 402 | 102,163 (0%) | 0% | 83.3 | 33,503 | Common Stock |
| Incyte | Steven H. Stein | EVP & Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 85.61 per share. | 28 Jun 2021 | 22,079 | 97,665 (0%) | 0% | 85.6 | 1,890,183 | Common Stock |
| Kura Oncology Inc | Steven H. Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2021 | 23,000 | 23,000 | - | - | Option to purchase common stock |